{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:57:09Z","timestamp":1791943029306,"version":"4.3.4"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00888","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T04:12:18Z","timestamp":1565323938000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Aldosterone Jeopardizes Myocardial Insulin and \u03b2-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2"],"prefix":"10.3389","volume":"10","author":[{"given":"Alessandro","family":"Cannavo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Liccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Bencivenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Gambino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rapacciuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cittadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazareno","family":"Paolocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1124\/mol.117.110130","article-title":"Structural determinants influencing the potency and selectivity of indazole-paroxetine hybrid G protein-coupled receptor kinase 2 inhibitors","volume":"92","author":"Bouley","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2013.00264","article-title":"Targeting cardiac \u03b2-adrenergic signaling via GRK2 inhibition for heart failure therapy","volume":"4","author":"Cannavo","year":"2013","journal-title":"Front. Physiol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10877","article-title":"Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases","volume":"7","author":"Cannavo","year":"2016","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jacc.2017.05.020","article-title":"\u03b21-blockade prevents post-ischemic myocardial decompensation via\u03b23AR-dependent protective sphingosine-1 phosphate signaling","volume":"70","author":"Cannavo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1204598","article-title":"Aldosterone and mineralocorticoid receptor system in cardiovascular physiology and pathophysiology","author":"Cannavo","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/14728222.2018.1406925","article-title":"GRK2 as a therapeutic target for heart failure","volume":"22","author":"Cannavo","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1161\/CIRCULATIONAHA.110.988642","article-title":"G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia","volume":"123","author":"Ciccarelli","year":"2011","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/cvr\/cvp252","article-title":"The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance","volume":"84","author":"Cipolletta","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"B10","first-page":"38","article-title":"Aging and cardiac autonomic control in chronic heart failure: methods and clinical implications","volume":"65","author":"D\u2019Addio","year":"2017","journal-title":"J. Gerontology Geriatrics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.mce.2011.07.019","article-title":"Non-genomic actions of aldosterone: from receptors and signals to membrane targets","volume":"350","author":"Dooley","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00395-011-0163-2","article-title":"EGFR trans-activation by urotensin II receptor is mediated by \u03b2-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy","volume":"106","author":"Esposito","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","article-title":"A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse","volume":"107","author":"Gao","year":"2010","journal-title":"Circ. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.2337\/db10-0771","article-title":"G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity","volume":"59","author":"Garcia-Guerra","year":"2010","journal-title":"Diabetes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/nm.2506","article-title":"Oxidation of CaMKII determines the cardiotoxic effects of aldosterone","volume":"17","author":"He","year":"2011","journal-title":"Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.107.093955","article-title":"Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells","volume":"50","author":"Hitomi","year":"2007","journal-title":"Hypertension"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1248\/bpb.b17-00291","article-title":"The aldosterone receptor antagonist eplerenone inhibits isoproterenol-induced collagen-I and 11\u03b2-HSD1 expression in rat cardiac fibroblasts and the left ventricle","volume":"40","author":"Hori","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1172\/JCI61996","article-title":"Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators","volume":"122","author":"Hu","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B19","first-page":"177","article-title":"Cardiac fibrosis in heart failure","volume":"65","author":"Komici","year":"2017","journal-title":"J. Gerontology Geriatrics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1124\/mol.115.098293","article-title":"Role of G protein-coupled receptor kinases 2 and 3 in \u03bc-opioid receptor desensitization and internalization","volume":"88","author":"Lowe","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/13813455.2011.584693","article-title":"G Protein-coupled receptor kinase 2 (GRK2): a novel modulator of insulin resistance","volume":"117","author":"Mayor","year":"2011","journal-title":"Arch. Physiol. Biochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"34531","DOI":"10.1074\/jbc.274.49.34531","article-title":"Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases","volume":"274","author":"Pitcher","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"B25","first-page":"1602","article-title":"Eplerenone attenuates cardiac dysfunction and oxidative stress in \u03b2-receptor stimulated myocardial infarcted rats","volume":"7","author":"Reddy","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.2215\/CJN.01410210","article-title":"Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome","volume":"5","author":"Schrier","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/1753944709341300","article-title":"Blocking aldosterone in heart failure","volume":"3","author":"Shafiq","year":"2009","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Sp\u00e4t","year":"2004","journal-title":"Physiol. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"H176","DOI":"10.1152\/ajpheart.00421.2002","article-title":"Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1\/2 signaling","volume":"284","author":"Stockand","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality","volume":"82","author":"Swedberg","year":"1990","journal-title":"Consensus Trial Study Group Circulation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/HYPERTENSIONAHA.109.140038","article-title":"Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin","volume":"54","author":"Tian","year":"2009","journal-title":"Hypertension"},{"key":"B32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/157436212800376708","article-title":"Genomic and non-genomic effects of aldosterone","volume":"7","author":"Verhovez","year":"2012","journal-title":"Current Signal Transduction Therapy"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1210\/en.2008-1018","article-title":"Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes","volume":"150","author":"Wada","year":"2009","journal-title":"Endocrinology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00888\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T22:24:12Z","timestamp":1569968652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00888\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":35,"alternative-id":["10.3389\/fphar.2019.00888"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00888","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,9]]},"article-number":"888"}}